alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Northeast Area
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        
                Northeast Area Cities

                    Washington, D.C.
                            Newark, Delaware
                            Boston, Massachusetts
                            Beltsville, Maryland (BHNRC)
                            Beltsville, Maryland (BARC)
                            Frederick, Maryland
                            Orono, Maine
                            Geneva, New York
                            Ithaca, New York
                            University Park, Pennsylvania
                            Wyndmoor, Pennsylvania
                            Kearneysville, West Virginia
                            Leetown, West Virginia
                            Burlington, Vermont


                    Civil Rights & EEO Policy StatementsSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Docs Choptank Watershed







Mainheadline bar


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov
Exhibit 10.13

Fees to be Paid to the Non-Employee Directors

of

Sealed Air Corporation (the “Corporation”)

2015

Members of the Board of Directors who are not officers or employees of the Corporation or any subsidiary of the Corporation (“non-employee directors”) shall be paid the following directors’ fees in cash, payable quarterly in arrears on or about the first day of the succeeding calendar quarter, which fees shall be in addition to retainers payable to non-employee directors under the Sealed Air Corporation 2002 Stock Plan for Non-Employee Directors:


	
(i)
	
for each non-employee director who is designated as chair of the Audit Committee, a fee of Six Thousand Two Hundred Fifty Dollars ($6,250) per calendar quarter for serving as chair, and for each other member of the Audit Committee, a fee of Two Thousand Five Hundred Dollars ($2,500) per calendar quarter for serving as a member;





	
(ii)
	
for each non-employee director who is designated as chair of the Nominating and Corporate Governance Committee, a fee of Three Thousand Seven Hundred Fifty Dollars ($3,750) per calendar quarter for serving as chair, and for each other member of the Nominating and Corporate Governance Committee, a fee of One Thousand Eight Hundred Seventy Five Dollars ($1,875) per calendar quarter for serving as a member;





	
(iii)
	
for each non-employee director who is designated as chair of the Organization and Compensation Committee, a fee of Five Thousand Dollars ($5,000) per calendar quarter for serving as chair, and for each other member of the Organization and Compensation Committee, a fee of Two Thousand Five Hundred Dollars ($2,500) per calendar quarter for serving as a member;





	
(iv)
	
a fee of Two Thousand Dollars ($2,000) per day for special assignments undertaken by a non-employee director at the request of the Board or any committee of the Board or for attending a director education program; and





	
(v)
	
meeting fees as approved by the Board of Directors for non-employee directors who serve on any special committee or for attendance at special meetings of the Board of Directors or a committee of the Board of Directors in the event of a major transaction, etc.




The amount of the Annual Retainer (as defined in the Sealed Air Corporation 2002 Stock Plan for Non-Employee Directors) to be paid to the non-employee directors of the Corporation who are elected at the 2015 Annual Meeting of Stockholders is $100,000 payable in shares of Common Stock plus $85,000 payable in cash unless the non-employee director elects payment of the cash portion in shares of Common Stock.

The amount of the Annual Retainer to be paid to the independent Chairman of the Board is $160,000 payable in shares of Common Stock plus $136,000 payable in cash unless the Chairman elects payment of the cash portion in shares of Common Stock.

Under the Sealed Air Corporation Deferred Compensation Plan for Directors, a non-employee director may elect to defer all or part of his or her Annual Retainer until the director retires from the Board. None of the other fees mentioned above are eligible to be deferred.
#### In the Matter of Mark Kressner and Michael B. Schulman, Attorneys.

Motion granted and the order of this court entered on May 16, 1985 (108 AD2d 334) is modified to reflect August 16, 1985 as the effective date of respondent Kressner’s suspension. Concur — Kupferman, J. P., Ross, Carro, Bloom and Kassal, JJ.
# L_2009085EN.01014901.xml

| 31.3.2009 | EN | Official Journal of the European Union | L 85/149 |
| --- | --- | --- | --- |

31.3.2009

EN

Official Journal of the European Union

L 85/149

---

Statement of revenue and expenditure for the Executive Agency for Health and Consumers for the financial year 2008 — Amending Budget No 2

(2009/285/EC)

REVENUE

| Title
  Chapter | Heading | Budget 2008 | Amending budget No 2 | New amount |
| --- | --- | --- | --- | --- |
| 1 | EUROPEAN COMMUNITY CONTRIBUTION |
| 1 0 | EUROPEAN COMMUNITY CONTRIBUTION | 4 440 000 | – 113 200 | 4 326 800 |
| | Title 1 — Total | 4 440 000 | – 113 200 | 4 326 800 |
| 2 | PARTICIPATION OF THIRD COUNTRIES |
| | Title 2 — Total | 93 500 | | 93 500 |
| | GRAND TOTAL | 4 533 500 | – 113 200 | 4 420 300 |

Title

Chapter

Heading

Budget 2008

Amending budget No 2

New amount

1

1

EUROPEAN COMMUNITY CONTRIBUTION

EUROPEAN COMMUNITY CONTRIBUTION

1 0

EUROPEAN COMMUNITY CONTRIBUTION

4 440 000

– 113 200

4 326 800

Title 1 — Total

Title 1 — Total

4 440 000

4 440 000

– 113 200

– 113 200

4 326 800

4 326 800

2

2

PARTICIPATION OF THIRD COUNTRIES

PARTICIPATION OF THIRD COUNTRIES

Title 2 — Total

Title 2 — Total

93 500

93 500

93 500

93 500

GRAND TOTAL

GRAND TOTAL

4 533 500

4 533 500

– 113 200

– 113 200

4 420 300

4 420 300

EXPENDITURE

| Title
  Chapter | Heading | Appropriations 2008 | Amending budget No 2 | New amount |
| --- | --- | --- | --- | --- |
| 1 | EXPENSES FOR STAFF LINKED TO THE AGENCY |
| 1 1 | STAFF IN ACTIVE EMPLOYMENT | 2 335 500 | – 113 200 | 2 222 300 |
| | Title 1 — Total | 2 737 000 | – 113 200 | 2 623 800 |
| 2 | CENTRAL SUPPORT COSTS |
| | Title 2 — Total | 989 000 | | 989 000 |
| 3 | EXPENDITURE LINKED TO THE AGENCY OPERATIONS |
| | Title 3 — Total | 807 500 | | 807 500 |
| | GRAND TOTAL | 4 533 500 | – 113 200 | 4 420 300 |

Title

Chapter

Heading

Appropriations 2008

Amending budget No 2

New amount

1

1

EXPENSES FOR STAFF LINKED TO THE AGENCY

EXPENSES FOR STAFF LINKED TO THE AGENCY

1 1

STAFF IN ACTIVE EMPLOYMENT

2 335 500

– 113 200

2 222 300

Title 1 — Total

Title 1 — Total

2 737 000

2 737 000

– 113 200

– 113 200

2 623 800

2 623 800

2

2

CENTRAL SUPPORT COSTS

CENTRAL SUPPORT COSTS

Title 2 — Total

Title 2 — Total

989 000

989 000

989 000

989 000

3

3

EXPENDITURE LINKED TO THE AGENCY OPERATIONS

EXPENDITURE LINKED TO THE AGENCY OPERATIONS

Title 3 — Total

Title 3 — Total

807 500

807 500

807 500

807 500

GRAND TOTAL

GRAND TOTAL

4 533 500

4 533 500

– 113 200

– 113 200

4 420 300

4 420 300

---
EXHIBIT 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

As Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of AMCORE Financial, Inc. (the
Company) for the quarterly period ended June 30, 2008 as filed with the Securities and Exchange Commission on the date hereof (the Report), William R. McManaman, as Chief Executive Officer of the Company, hereby
certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                        
|------------------------
|/s/ William R. McManaman
|William R. McManaman    
|Chief Executive Officer 
|August 11, 2008         

This certification accompanies the Report pursuant to § 906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by § 906 of the Sarbanes-Oxley Act of 2002 has been provided to AMCORE Financial, Inc. and will be retained by AMCORE Financial, Inc. and furnished to the
Securities and Exchange Commission or its staff upon request.
FORM 10-Q/A


                       SECURITIES AND EXCHANGE COMMISSION


                             Washington, D.C. 20549


              (x) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 1997 OR

         ( )      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
                   OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE
                   REQUIRED)
For the transition period from...................to...........

Commission file number 0-11949

                          SILVER SCREEN PARTNERS, L.P.
                        (A Delaware Limited Partnership)
                  (Exact name of registrant as specified in its
                Certificate and Agreement of Limited Partnership)

Delaware                                                         13-3163899
-------------------------------                              -------------------
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                               Identification No.)

c/o Chelsea Piers
Pier 62 - Suite 300
New York, New York                                                      10011
----------------------------------------                              ----------
(Address of principal executive offices)                              (zip Code)

Registrant's telephone number, including area code (212) 336-6700

Securities registered pursuant to Section 12 (b) of the Act: NONE

Securities registered pursuant to Section 12 (g) of the Act:

                      UNITS OF LIMITED PARTNERSHIP INTEREST

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months,  and (2) has been subject to such  requirements for the
past 90 days.

                                    YES    X              NO 
                                        --------             ----------



                                       1
<PAGE>



                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant has caused this report to be signed on its behalf by the  undersigned
thereunto duly authorized.

                                            SILVER  SCREEN  PARTNERS,  L.P.,
                                            a Delaware limited partnership

                                            By: Silver Screen Management,  Inc.,
                                            Managing General Partner


Date:  November 13, 1997                By:    /s/ Roland W. Betts
                                            --------------------------------
                                            Roland W. Betts, President



                                        7
<PAGE>
#### Town & Travel Casuals, Inc., Appellant, v A. J. Armstrong Co., Inc., Respondent, et al., Defendant. —

Order and judgment (one paper), Supreme Court, New York County (Martin Stecher, J.), entered on or about January 24, 1984, and judgment of said court entered on February 28, 1984, unanimously affirmed for the reasons stated by Martin Stecher, J., at Trial Term. Respondent shall recover of appellant one bill of $75 costs and disbursements of these appeals. Concur — Sandler, J. P., Cairo, Bloom and Kassal, JJ.
#### The People of the State of New York, Respondent, v Michael Vanness, Appellant.

[941 NYS2d 892]

Appeal from a judgment of the County Court of Warren County (Hall Jr., J.), rendered May 26, 2010, convicting defendant upon his plea of guilty of the crime of possessing a sexual performance by a child (three counts).

Defendant was charged in an indictment with three counts of possessing a sexual performance by a child and pleaded guilty to all of the charges shortly after County Court denied his request for a *Mapp*hearing. Under the terms of the plea agreement, defendant was to be sentenced to no more than 2 to 4 years in prison on each count, to run consecutively to one another and concurrently to the sentence imposed on a prior conviction. Defendant was ultimately sentenced to IV2 to 3 years on each count, for an aggregate prison term of 4V2 to 9 years, to run concurrently to the prior sentence. He now appeals.

Appellate counsel seeks to be relieved of his assignment of representing defendant on the ground that there are no nonfrivolous issues to be raised on appeal. However, it appears that defendant’s plea was conditioned upon his right to appeal County Court’s decision denying his requested *Mapp*hearing. This issue was not addressed by appellate counsel. Therefore, we can not agree that there are no nonfrivolous issues to be raised on appeal. Accordingly, without passing judgment on the ultimate merit of this issue, we grant counsel’s application to withdraw and assign new counsel to address this issue and any others that the record may disclose *(see People v Stokes,*95 NY2d 633, 634 [2001]; *People v Garren,*74 AD3d 1578 [2010]; *People v Cruwys,*113 AD2d 979, 980 [1985], *lv denied*67 NY2d 650 [1986]).

Rose, J.P., Lahtinen, Kavanagh, Stein and Egan Jr., JJ., concur. Ordered that the decision is withheld, application to be relieved of assignment granted and new counsel to be assigned.
# L_2010172DE.01000502.xml

| 7.7.2010 | DE | Amtsblatt der Europäischen Union | L 172/5 |
| --- | --- | --- | --- |

7.7.2010

DE

Amtsblatt der Europäischen Union

L 172/5

---

Berichtigung der Entscheidung 2009/28/EG der Kommission vom 13. Januar 2009 über die Nichtaufnahme von Flurprimidol in Anhang I der Richtlinie 91/414/EWG des Rates und den Widerruf der Zulassungen für Pflanzenschutzmittel mit diesem Wirkstoff

(
  Amtsblatt der Europäischen Union L 10 vom 15. Januar 2009
  )

Amtsblatt der Europäischen Union L 10 vom 15. Januar 2009

Seite 25, Erwägungsgrund 5:

anstatt:

| „(5) | Bei der Bewertung dieses Wirkstoffs wurden einige bedenkliche Aspekte ermittelt. Die verfügbaren Informationen zeigten insbesondere, dass die Exposition des Anwenders bei allen geprüften Szenarios und Anwendungsbedingungen den annehmbaren AOEL-Wert überschreitet. Darüber hinaus fehlten Daten zum Verunreinigungsprofil der in toxikologischen Studien verwendeten Proben. Somit konnte anhand der vorliegenden Informationen nicht der Schluss gezogen werden, dass Flurprimidol die für die Aufnahme in Anhang I der Richtlinie 91/414/EWG erforderlichen Kriterien erfüllt.“ |
| --- | --- |

„(5)

Bei der Bewertung dieses Wirkstoffs wurden einige bedenkliche Aspekte ermittelt. Die verfügbaren Informationen zeigten insbesondere, dass die Exposition des Anwenders bei allen geprüften Szenarios und Anwendungsbedingungen den annehmbaren AOEL-Wert überschreitet. Darüber hinaus fehlten Daten zum Verunreinigungsprofil der in toxikologischen Studien verwendeten Proben. Somit konnte anhand der vorliegenden Informationen nicht der Schluss gezogen werden, dass Flurprimidol die für die Aufnahme in Anhang I der Richtlinie 91/414/EWG erforderlichen Kriterien erfüllt.“

muss es heißen:

| „(5) | Bei der Bewertung dieses Wirkstoffs wurden einige bedenkliche Aspekte ermittelt. Die verfügbaren Informationen zeigten insbesondere, dass die Exposition des Anwenders und des Betriebspersonals bei allen geprüften Szenarios und Anwendungsbedingungen den AOEL-Wert (annehmbare Anwenderexposition) überschreitet. Darüber hinaus fehlten Daten zum Verunreinigungsprofil der in toxikologischen Studien verwendeten Chargen. Somit konnte anhand der vorliegenden Informationen nicht der Schluss gezogen werden, dass Flurprimidol die für die Aufnahme in Anhang I der Richtlinie 91/414/EWG erforderlichen Kriterien erfüllt.“ |
| --- | --- |

„(5)

Bei der Bewertung dieses Wirkstoffs wurden einige bedenkliche Aspekte ermittelt. Die verfügbaren Informationen zeigten insbesondere, dass die Exposition des Anwenders und des Betriebspersonals bei allen geprüften Szenarios und Anwendungsbedingungen den AOEL-Wert (annehmbare Anwenderexposition) überschreitet. Darüber hinaus fehlten Daten zum Verunreinigungsprofil der in toxikologischen Studien verwendeten Chargen. Somit konnte anhand der vorliegenden Informationen nicht der Schluss gezogen werden, dass Flurprimidol die für die Aufnahme in Anhang I der Richtlinie 91/414/EWG erforderlichen Kriterien erfüllt.“

---
[Federal Register Volume 86, Number 126 (Tuesday, July 6, 2021)]
[Notices]
[Pages 35521-35522]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14282]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary & Integrative Health; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Complementary and 
Integrative Health Special Emphasis Panel; Exploratory Clinical 
Trials of Mind and Body Interventions (MB).
    Date: July 29, 2021.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Center for Complementary and Integrative, 
Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: SUSHMITA Purkayastha, Ph.D., Scientific Review 
Officer, Office of Scientific Review, Division of Extramural 
Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, 
Bethesda, MD 20892-5475 <a href="/cdn-cgi/l/email-protection#483b3d3b2025213c2966383d3a232931293b3c202908262120662f273e"><span class="__cf_email__" data-cfemail="423137312a2f2b36236c32373029233b2331362a23022c2b2a6c252d34">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.213, 
Research and Training

[[Page 35522]]

in Complementary and Alternative Medicine, National Institutes of 
Health, HHS)

    Dated: June 29, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-14282 Filed 7-2-21; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
U.S. flagAn official website of the United States government
                    Here's how you know **Official websites use .gov**
                            
                            A **.gov** website belongs to an official government organization in the United States.
 **Secure .gov websites use HTTPS**
                            
                            A **lock** (                            
                              A locked padlock                                                      
                            
                            ) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.


Menu Agricultural Research Service
						
                    U.S. DEPARTMENT OF AGRICULTURE
 Eastern Regional Research Center: Wyndmoor, PA
 close



    Research

                    Research Projects
                                    Publications
                                    Collaborations
                                    News
                People

                    Staff Listing
                                    Careers


        


                    About ERRC
                        Greetings from the Director
                                    Directions/Lodging
                                    History and Accomplishments
                    Our Work
                        Biomass Pyrolysis Research
                                    IPMP 2013
                                    IPMP Dynamic Prediction
                                    IPMP Global Fit
                                    Pathogen Modeling Program (PMP)
                                    Predictive Microbiology Information Portal (PMIP)
                                    PoultryFARMSearch small
                    Search
            
            ARS Home
                                About ARS
                                Contact Us




ARS Home Northeast Area Wyndmoor, Pennsylvania Eastern Regional Research Center Docs Poultry





- Research
- Highlights
- Publications
- Presentation
- Models
- Data
- Contact

PoultryFARM - Presentationheadline bar  Presentation numbers correspond to publication numbers.  There are two types of presentations: oral (O) and poster (P).  Files are PowerPoint or PDF. O19
P21
P23
O26
P26
O27
P27
O28
P28
O29P30
O31
O32
O37
P37
P38
O41
P43
O44
O45P48
P50
O51
P51
O52
P53
O54
O56
O57
O60O70
O71


Return to top


Connect with ARS Sign up


ARS Home
                            USDA.gov
                            Plain Writing
                            Policies & Links
                            Civil Rights Statements
                            FOIA
                            Accessibility Statement
                            Privacy Policy
                            Non-Discrimination Statement
                            Quality of Information
                            USA.gov
                            WhiteHouse.gov